Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L-lactate dehydrogenase activity	LDHAL6A LDHAL6B LDHA	1.04e-05	5	204	3	GO:0004459
GeneOntologyMolecularFunction	lactate dehydrogenase activity	LDHAL6A LDHAL6B LDHA	2.05e-05	6	204	3	GO:0004457
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DNAH6 DNHD1 DNAH1	2.89e-05	18	204	4	GO:0008569
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	ALLC AGMAT PADI2	1.63e-04	11	204	3	GO:0016813
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH5 DNAH6 DNHD1 DNAH1	1.79e-04	28	204	4	GO:0051959
GeneOntologyMolecularFunction	C-rich single-stranded DNA binding	PCBP3 PCBP2	3.10e-04	3	204	2	GO:1990829
GeneOntologyMolecularFunction	integrin binding	ITGA5 SVEP1 CD177 ICAM3 FERMT1 ADAMTS13 TNN IL1B	4.48e-04	175	204	8	GO:0005178
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH5 DNAH6 DNHD1 DNAH1	5.36e-04	37	204	4	GO:0045505
GeneOntologyMolecularFunction	ABC-type bile acid transporter activity	ABCC11 ABCB11	6.15e-04	4	204	2	GO:0015432
GeneOntologyMolecularFunction	ATPase-coupled organic acid transmembrane transporter activity	ABCC11 ABCB11	6.15e-04	4	204	2	GO:0033283
GeneOntologyMolecularFunction	ATPase-coupled monocarboxylic acid transmembrane transporter activity	ABCC11 ABCB11	6.15e-04	4	204	2	GO:0033285
GeneOntologyMolecularFunction	ATPase-coupled carboxylic acid transmembrane transporter activity	ABCC11 ABCB11	6.15e-04	4	204	2	GO:0033284
GeneOntologyCellularComponent	axonemal dynein complex	DNAH5 DNAH6 DNHD1 DNAH1	1.00e-04	25	207	4	GO:0005858
GeneOntologyCellularComponent	inner dynein arm	DNAH6 DNHD1 DNAH1	1.09e-04	10	207	3	GO:0036156
GeneOntologyCellularComponent	dynein complex	DISC1 DNAH5 DNAH6 DNHD1 DNAH1	1.93e-04	54	207	5	GO:0030286
Domain	ARM-like	STK36 UNC45A NBEAL2 ANKAR AP1G2 NCAPD3 IPO8 NBEA ODAD2 AP4E1 IFRD1 LTN1 TTI1	9.43e-06	270	205	13	IPR011989
Domain	L_LDH	LDHAL6A LDHAL6B LDHA	1.28e-05	5	205	3	PS00064
Domain	L-lactate_DH	LDHAL6A LDHAL6B LDHA	1.28e-05	5	205	3	IPR011304
Domain	L-lactate_DH_AS	LDHAL6A LDHAL6B LDHA	1.28e-05	5	205	3	IPR018177
Domain	DUF4704	NBEAL1 NBEAL2 NBEA	1.28e-05	5	205	3	IPR031570
Domain	DUF4704	NBEAL1 NBEAL2 NBEA	1.28e-05	5	205	3	PF15787
Domain	Dynein_HC_stalk	DNAH5 DNAH6 DNHD1 DNAH1	1.29e-05	14	205	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH6 DNHD1 DNAH1	1.29e-05	14	205	4	IPR013602
Domain	DHC_N2	DNAH5 DNAH6 DNHD1 DNAH1	1.29e-05	14	205	4	PF08393
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH5 DNAH6 DNAH1	1.29e-05	14	205	4	IPR011704
Domain	MT	DNAH5 DNAH6 DNHD1 DNAH1	1.29e-05	14	205	4	PF12777
Domain	AAA_5	MDN1 DNAH5 DNAH6 DNAH1	1.29e-05	14	205	4	PF07728
Domain	DHC_fam	DNAH5 DNAH6 DNHD1 DNAH1	1.75e-05	15	205	4	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH6 DNHD1 DNAH1	1.75e-05	15	205	4	PF03028
Domain	Dynein_heavy_dom	DNAH5 DNAH6 DNHD1 DNAH1	1.75e-05	15	205	4	IPR004273
Domain	ARM-type_fold	STK36 NBEAL1 UNC45A NBEAL2 ANKAR AP1G2 NCAPD3 IPO8 NBEA ODAD2 AP4E1 IFRD1 LTN1 TTI1	2.40e-05	339	205	14	IPR016024
Domain	PH_BEACH	NBEAL1 NBEAL2 NBEA	2.54e-05	6	205	3	PF14844
Domain	ConA-like_dom	NBEAL1 CLSTN2 SVEP1 RYR2 TRIM11 NBEAL2 FAT4 NBEA NPTXR MDGA1 NEURL4	3.15e-05	219	205	11	IPR013320
Domain	Lactate/malate_DH_N	LDHAL6A LDHAL6B LDHA	7.01e-05	8	205	3	IPR001236
Domain	PH-BEACH_dom	NBEAL1 NBEAL2 NBEA	7.01e-05	8	205	3	IPR023362
Domain	L-lactate/malate_DH	LDHAL6A LDHAL6B LDHA	7.01e-05	8	205	3	IPR001557
Domain	-	NBEAL1 NBEAL2 NBEA	7.01e-05	8	205	3	2.30.29.40
Domain	Ldh_1_N	LDHAL6A LDHAL6B LDHA	7.01e-05	8	205	3	PF00056
Domain	PH_BEACH	NBEAL1 NBEAL2 NBEA	7.01e-05	8	205	3	PS51783
Domain	-	LDHAL6A LDHAL6B LDHA	1.04e-04	9	205	3	3.90.110.10
Domain	Lactate/malate_DH_C	LDHAL6A LDHAL6B LDHA	1.04e-04	9	205	3	IPR022383
Domain	Ldh_1_C	LDHAL6A LDHAL6B LDHA	1.04e-04	9	205	3	PF02866
Domain	BEACH	NBEAL1 NBEAL2 NBEA	1.04e-04	9	205	3	PS50197
Domain	Beach	NBEAL1 NBEAL2 NBEA	1.04e-04	9	205	3	PF02138
Domain	-	NBEAL1 NBEAL2 NBEA	1.04e-04	9	205	3	1.10.1540.10
Domain	Beach	NBEAL1 NBEAL2 NBEA	1.04e-04	9	205	3	SM01026
Domain	Lactate_DH/Glyco_Ohase_4_C	LDHAL6A LDHAL6B LDHA	1.04e-04	9	205	3	IPR015955
Domain	BEACH_dom	NBEAL1 NBEAL2 NBEA	1.04e-04	9	205	3	IPR000409
Domain	VIT	PARP4 VWA5B1 ITIH5	1.48e-04	10	205	3	PS51468
Domain	VIT	PARP4 VWA5B1 ITIH5	1.48e-04	10	205	3	IPR013694
Domain	-	STK36 UNC45A ANKAR AP1G2 NCAPD3 IPO8 ODAD2 AP4E1 IFRD1 TTI1	1.77e-04	222	205	10	1.25.10.10
Domain	VWFA	SVEP1 PARP4 MDN1 HMCN2 VWA5B1 ITIH5	2.84e-04	82	205	6	PS50234
Domain	VWA	SVEP1 PARP4 MDN1 HMCN2 VWA5B1 ITIH5	3.24e-04	84	205	6	SM00327
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH6 DNAH1	4.34e-04	14	205	3	IPR024317
Domain	AAA_8	DNAH5 DNAH6 DNAH1	4.34e-04	14	205	3	PF12780
Domain	-	NBEAL1 CLSTN2 SVEP1 FAT4 NBEA NPTXR	6.28e-04	95	205	6	2.60.120.200
Domain	Mib_Herc2	HERC2 MIB2	7.09e-04	4	205	2	IPR010606
Domain	MIB_HERC2	HERC2 MIB2	7.09e-04	4	205	2	PS51416
Domain	MIB_HERC2	HERC2 MIB2	7.09e-04	4	205	2	PF06701
Domain	Calponin/LIMCH1	CNN1 CNN3	7.09e-04	4	205	2	IPR001997
Domain	VWF_A	SVEP1 PARP4 MDN1 HMCN2 VWA5B1 ITIH5	7.81e-04	99	205	6	IPR002035
Domain	AAA	MDN1 DNAH5 DNAH6 ABCC11 RNF213 ABCB11 YME1L1	1.07e-03	144	205	7	SM00382
Domain	AAA+_ATPase	MDN1 DNAH5 DNAH6 ABCC11 RNF213 ABCB11 YME1L1	1.07e-03	144	205	7	IPR003593
Domain	-	SVEP1 PARP4 MDN1 VWA5B1 ITIH5	1.32e-03	74	205	5	3.40.50.410
Domain	Growth_fac_rcpt_	TMEM67 SVEP1 HMCN2 FAT4 STAB2 CUBN TNN	1.70e-03	156	205	7	IPR009030
Domain	Calponin_repeat	CNN1 CNN3	1.75e-03	6	205	2	IPR000557
Domain	Calponin	CNN1 CNN3	1.75e-03	6	205	2	PF00402
Domain	CALPONIN_1	CNN1 CNN3	1.75e-03	6	205	2	PS01052
Domain	CALPONIN_2	CNN1 CNN3	1.75e-03	6	205	2	PS51122
Pubmed	A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins.	PCBP4 PCBP3 PCBP2	8.77e-07	4	211	3	14612387
Pubmed	Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.	PCBP4 PCBP3 PCBP2	2.18e-06	5	211	3	23640898
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	CRACD MDN1 PNPLA6 NCAPD3 RNF213 LTN1 YME1L1	3.53e-06	104	211	7	31240132
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	STK36 INPPL1 PLXND1 ITGA5 DYSF JAK3 MDN1 PNPLA6 NBEAL2 BANP AP1G2 FGFR2 HERC2 TTC38 BAHCC1 DPH2 MIB2 MST1R RPAP1 USP40 PAXIP1	4.31e-06	1105	211	21	35748872
Pubmed	Identification of two novel mammalian genes establishes a subfamily of KH-domain RNA-binding proteins.	PCBP4 PCBP3 PCBP2	4.34e-06	6	211	3	10936052
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MAP1A CLSTN2 C2CD5 PNPLA6 HMCN2 PEX5 BAHCC1 WDR72 RNF31 P3H3 ZCCHC8 RNF213 ZNF526 RNH1 BAZ2A LTN1 PADI2 YME1L1 ANKS3 SP140 ZNF646	5.02e-06	1116	211	21	31753913
Pubmed	MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.	RIPK2 NLRC4 IL1B	7.57e-06	7	211	3	17403772
Pubmed	Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.	PRKD1 MAPK1 IL1B	7.57e-06	7	211	3	16539678
Pubmed	FGF signaling regulates salivary gland branching morphogenesis by modulating cell adhesion.	ITGA5 FGFR2 MAPK1	2.56e-05	10	211	3	36861436
Pubmed	Agrin has a pathological role in the progression of oral cancer.	LPIN1 TRIM11 PNPLA6 RNF31 ZCCHC8 SYNE1 LDHA TNN	2.94e-05	197	211	8	29872149
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	PTDSS1 UNC45A PARP4 HERC2 NCAPD3 NBAS LTN1 NEURL4	3.51e-05	202	211	8	33005030
Pubmed	Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing.	PRTN3 CD177	3.66e-05	2	211	2	18462208
Pubmed	Mori folium inhibits interleukin-1β-induced expression of matrix metalloproteinases and inflammatory mediators by suppressing the activation of NF-κB and p38 MAPK in SW1353 human chondrocytes.	MAPK1 IL1B	3.66e-05	2	211	2	26707272
Pubmed	Molecular cloning and gene mapping of human basic and acidic calponins.	CNN1 CNN3	3.66e-05	2	211	2	8526917
Pubmed	Competitively disrupting the neutrophil-specific receptor-autoantigen CD177:proteinase 3 membrane complex reduces anti-PR3 antibody-induced neutrophil activation.	PRTN3 CD177	3.66e-05	2	211	2	35063507
Pubmed	Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.	PRTN3 CD177	3.66e-05	2	211	2	19185066
Pubmed	NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense.	NLRC4 IL1B	3.66e-05	2	211	2	22484733
Pubmed	IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system.	ADAMTS13 IL1B	3.66e-05	2	211	2	21732076
Pubmed	A novel specific cleavage of IκBα protein in acute myeloid leukemia cells involves protease PR3.	PRTN3 NFKBIA	3.66e-05	2	211	2	31125555
Pubmed	Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency.	NFKBIA IL1B	3.66e-05	2	211	2	32750042
Pubmed	OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.	OTUD7B MAP3K14	3.66e-05	2	211	2	27499151
Pubmed	Glycogen synthase kinase-3 phosphorylates CdGAP at a consensus ERK 1 regulatory site.	ARHGAP31 GSK3A	3.66e-05	2	211	2	17158447
Pubmed	NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils.	PRTN3 CD177	3.66e-05	2	211	2	17244676
Pubmed	Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.	DISC1 GSK3A	3.66e-05	2	211	2	21498050
Pubmed	Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.	AGER IL1B	3.66e-05	2	211	2	20739563
Pubmed	Characterization of the CD177 interaction with the ANCA antigen proteinase 3.	PRTN3 CD177	3.66e-05	2	211	2	28240246
Pubmed	Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase.	ABCB11 MAPK1	3.66e-05	2	211	2	14762791
Pubmed	Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression.	PRTN3 CD177	3.66e-05	2	211	2	20491791
Pubmed	The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms.	PCBP4 PCBP3	3.66e-05	2	211	2	12003487
Pubmed	Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.	PRTN3 AGER	3.66e-05	2	211	2	28428279
Pubmed	IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease.	NLRC4 IL1B	3.66e-05	2	211	2	24054992
Pubmed	Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm.	DNAH5 ODAD2	3.66e-05	2	211	2	24203976
Pubmed	Monosodium urate crystal-induced pro-interleukin-1β production is post-transcriptionally regulated via the p38 signaling pathway in human monocytes.	MAPK1 IL1B	3.66e-05	2	211	2	27694988
Pubmed	A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors.	PRTN3 CD177	3.66e-05	2	211	2	18854317
Pubmed	Expression of receptor for advanced glycation end products in sarcoid granulomas.	AGER BTNL2	3.66e-05	2	211	2	17170388
Pubmed	The Transient Receptor Potential Vanilloid 2 (TRPV2) Channel Facilitates Virus Infection Through the Ca2+ -LRMDA Axis in Myeloid Cells.	TRPV2 LRMDA	3.66e-05	2	211	2	36261399
Pubmed	The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.	MST1R TGM4	3.66e-05	2	211	2	20596668
Pubmed	Hydrogen peroxide prolongs nuclear localization of NF-kappaB in activated cells by suppressing negative regulatory mechanisms.	OTUD7B NFKBIA	3.66e-05	2	211	2	18474597
Pubmed	Primary Ciliary Dyskinesia	DNAH5 ODAD2 DNAH1 HYDIN	4.14e-05	32	211	4	20301301
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	LDHAL6A UNC45A MDN1 TBC1D15 PCBP3 IPO8 ABCC11 LDHA RNH1 LTN1 AGK TTI1 PCBP2 YME1L1	4.62e-05	647	211	14	26618866
Pubmed	An investigation into the human serum "interactome".	SPATA31A7 NLRC4 RYR2 PLA2G4F IGDCC4 TGM4 AP4E1	6.30e-05	162	211	7	15174051
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH5 DNAH6 DNAH1	7.63e-05	14	211	3	9373155
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PLXND1 RYR2 OTUD7B NFKBIA ZNF638 PEX5 PCDH10 FAT4 FERMT1 RNF213 NBEA LDHA AP4E1 ANO6 CDK5RAP2	8.91e-05	777	211	15	35844135
Pubmed	Defining the membrane proteome of NK cells.	ACAA1 CNST PTDSS1 LRRC59 RPL23 PARP4 MDN1 PNPLA6 NBEAL2 HERC2 NCAPD3 RNF213 LDHA SLC4A2 NBAS ANO6 PAM PCBP2 YME1L1	1.01e-04	1168	211	19	19946888
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	PRTN3 LDHAL6A DYSF TTC38 FAT4 PCBP3 CD177 RTN4RL1 LCAT CUBN LDHA TGM4 IGFALS RNH1 ANO6 DNM3 PAM PCBP2	1.02e-04	1070	211	18	23533145
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	HFE CYP1B1 JAK3 PARP4 POT1 LCAT SLC4A2 IGFALS ABCB11 IL1B	1.05e-04	374	211	10	19625176
Pubmed	IL-1β suppresses nephronectin expression in osteoblasts via ERK1/2 and JNK.	MAPK1 IL1B	1.09e-04	3	211	2	28851654
Pubmed	JMJD3 is involved in neutrophil membrane proteinase 3 overexpression during the hyperinflammatory response in early sepsis.	PRTN3 IL1B	1.09e-04	3	211	2	29621735
Pubmed	OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.	OTUD7B MAP3K14	1.09e-04	3	211	2	33198776
Pubmed	Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.	AGER IL1B	1.09e-04	3	211	2	28224704
Pubmed	Lipid signalling drives proteolytic rewiring of mitochondria by YME1L.	LPIN1 YME1L1	1.09e-04	3	211	2	31695197
Pubmed	NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection.	NLRC4 IL1B	1.09e-04	3	211	2	22547706
Pubmed	No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia.	PRSS16 PGBD1	1.09e-04	3	211	2	22488895
Pubmed	TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung.	NLRC4 IL1B	1.09e-04	3	211	2	25085021
Pubmed	Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.	PRKD1 MAPK1	1.09e-04	3	211	2	19804826
Pubmed	RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis.	FGFR2 MAPK1	1.09e-04	3	211	2	17694057
Pubmed	Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia.	MAPK1 IL1B	1.09e-04	3	211	2	14670631
Pubmed	Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils.	PRTN3 CD177	1.09e-04	3	211	2	22266279
Pubmed	Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.	ITGA5 FGFR2	1.09e-04	3	211	2	27340869
Pubmed	h3/Acidic calponin: an actin-binding protein that controls extracellular signal-regulated kinase 1/2 activity in nonmuscle cells.	CNN3 MAPK1	1.09e-04	3	211	2	20181831
Pubmed	Identification of a novel human lactate dehydrogenase gene LDHAL6A, which activates transcriptional activities of AP1(PMA).	LDHAL6A LDHAL6B	1.09e-04	3	211	2	18351441
Pubmed	Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.	FAT4 ADAM12	1.09e-04	3	211	2	37751246
Pubmed	Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3.	PRTN3 IL1B	1.09e-04	3	211	2	10339575
Pubmed	Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells.	NFKBIA MAPK1	1.09e-04	3	211	2	15173174
Pubmed	Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1.	LDHAL6B LDHA	1.09e-04	3	211	2	12107167
Pubmed	Quercetin negatively regulates IL-1β production in Pseudomonas aeruginosa-infected human macrophages through the inhibition of MAPK/NLRP3 inflammasome pathways.	MAPK1 IL1B	1.09e-04	3	211	2	32817626
Pubmed	Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion.	NFKBIA MAPK1	1.09e-04	3	211	2	15671028
Pubmed	Vacuolar Protein Sorting 4B (VPS4B) Regulates Apoptosis of Chondrocytes via p38 Mitogen-Activated Protein Kinases (MAPK) in Osteoarthritis.	MAPK1 IL1B	1.09e-04	3	211	2	28744712
Pubmed	A Novel Diterpenoid Suppresses Osteoclastogenesis and Promotes Osteogenesis by Inhibiting Ifrd1-Mediated and IκBα-Mediated p65 Nuclear Translocation.	NFKBIA IFRD1	1.09e-04	3	211	2	29091322
Pubmed	Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.	AGER MAPK1	1.09e-04	3	211	2	28849117
Pubmed	THE BALANCE OF IL-1β, IL-10 AND THE LEVEL OF IKBα EXPRESSION IN CHILDREN WITH CHRONIC CATARRHAL GINGIVITIS AND GASTRODUODENITIS.	NFKBIA IL1B	1.09e-04	3	211	2	33851594
Pubmed	Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGE-dependent ERK1/2 activation.	AGER MAPK1	1.09e-04	3	211	2	20361273
Pubmed	NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization.	HERC2 NEURL4	1.09e-04	3	211	2	28977907
Pubmed	DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia.	DNAH5 DNAH6	1.09e-04	3	211	2	26918822
Pubmed	Distinct Roles of IL-1β and IL-18 in NLRC4-Induced Autoinflammation.	NLRC4 IL1B	1.09e-04	3	211	2	33178225
Pubmed	Functional analysis of rat acidic calponin.	CNN1 CNN3	1.09e-04	3	211	2	12033495
Pubmed	When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.	GSK3A MAPK1	1.09e-04	3	211	2	34072862
Pubmed	Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.	FGFR2 MAPK1	1.09e-04	3	211	2	11876253
Pubmed	RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism.	PTDSS1 RYR2	1.09e-04	3	211	2	26742492
Pubmed	Xenon enhances LPS-induced IL-1β expression in microglia via the extracellular signal-regulated kinase 1/2 pathway.	MAPK1 IL1B	1.09e-04	3	211	2	20680516
Pubmed	Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells.	NFKBIA IL1B	1.09e-04	3	211	2	17681786
Pubmed	The DISC1 R264Q variant increases affinity for the dopamine D2 receptor and increases GSK3 activity.	DISC1 GSK3A	1.09e-04	3	211	2	32493513
Pubmed	Tyrosine phosphorylation of calponins. Inhibition of the interaction with F-actin.	CNN1 CNN3	1.09e-04	3	211	2	15206927
Pubmed	Epithelial expression of Gata4 and Sox2 regulates specification of the squamous-columnar junction via MAPK/ERK signaling in mice.	FGFR2 SYNE1 MAPK1	1.16e-04	16	211	3	33495473
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	HFE CYP1B1 JAK3 PARP4 POT1 LCAT SLC4A2 IGFALS ABCB11 IL1B	1.23e-04	381	211	10	18676680
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DGKH LRRC59 TTC1 DECR1 RPL23 MDN1 PEX5 HERC2 TBC1D15 IPO8 ZCCHC8 SYNE1 RNF213 YARS1 NBAS MRM3 RPAP1 BAZ2A AGK CDK5RAP2 YME1L1 NEURL4	1.23e-04	1496	211	22	32877691
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	HFE CYP1B1 JAK3 PARP4 POT1 LCAT SLC4A2 IGFALS ABCB11 IL1B	1.25e-04	382	211	10	19170196
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HFE CYP1B1 TMEM67 PTDSS1 LRRC59 PLXND1 ITGA5 FAM234B NCAPD3 FAT4 P3H3 RNF213 ADAM12 SLC4A2 MST1R ANO6 LTN1 PAM TTI1	1.45e-04	1201	211	19	35696571
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DISC1 DGKH GAL3ST2 TMEM132B PARP4 MDN1 ANP32E PCDH10 FAT4 MUC19 RNF213 NBEA RPAP1 RXFP1	1.78e-04	736	211	14	29676528
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	PLXND1 ADAMTSL4 ICAM3 ADAMTS13 LCAT IGFALS TNN MDGA1	1.87e-04	257	211	8	16335952
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	PTDSS1 UNC45A RPL23 TFB2M HERC2 TBC1D15 IPO8 YARS1 RPAP1 LTN1 AGK TTI1 PCBP2	2.08e-04	657	211	13	36180527
Pubmed	Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans.	NLRC4 IL1B	2.18e-04	4	211	2	19222370
Pubmed	Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.	OTUD7B NFKBIA	2.18e-04	4	211	2	30213788
Pubmed	Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.	NFKBIA BANP	2.18e-04	4	211	2	18981184
Pubmed	Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling.	NLRC4 IL1B	2.18e-04	4	211	2	26516283
Pubmed	Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage.	RIPK2 NLRC4	2.18e-04	4	211	2	21683629
Pubmed	Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.	RIPK2 NLRC4	2.18e-04	4	211	2	15190255
Pubmed	Cutting edge: IL-1β processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and caspase-1.	NLRC4 IL1B	2.18e-04	4	211	2	23024281
Pubmed	Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.	ITGA5 FGFR2	2.18e-04	4	211	2	15728256
Pubmed	Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation.	PRTN3 CD177	2.18e-04	4	211	2	21193407
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 NBEAL2 NBEA	3.46e-05	9	137	3	1230
GeneFamily	Dyneins, axonemal	DNAH5 DNAH6 DNAH1	2.68e-04	17	137	3	536
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	SSC4D AGER STAB2	1.09e-03	27	137	3	1253
Coexpression	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	TMEM67 XIRP1 GARIN1A RIPK2 OTUD7B ARHGAP31 HPS4 NFKBIA PLA2G5 DNHD1 FNDC3B ABCC11 RNF213 BPIFA3 IL1B	3.87e-06	452	209	15	M18685
Coexpression	GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	ACP6 CNST PARP4 PNPLA6 HERC2 CNN3 FAM234B TBC1D15 MAP3K14 MIB2	5.05e-06	200	209	10	M9763
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	STK36 DGKH RYR2 AP1G2 CACNA1G ACAP3 SYNE1 RNF213 HYDIN	7.88e-06	166	209	9	M39026
Coexpression	GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR	PLXND1 SYNE1 YARS1 FAN1	2.57e-05	22	209	4	M39156
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 ALLC GGT5 KCNJ5 TDRD6 P3H3 MUC19 ADAM12 GSK3A FICD	7.31e-09	166	211	10	c11dcf9705b85ac3da6ae86358f5ffd64ae8327e
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 PPOX HYDIN CFAP46	3.56e-08	196	211	10	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 PPOX HYDIN CFAP46	3.73e-08	197	211	10	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 PPOX HYDIN CFAP46	3.73e-08	197	211	10	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PRSS16 ITPKA BANP DIO3 RTN4RL1 ADAM12 NPTXR MAPK1 NPAS4	3.86e-08	148	211	9	223d6a640f3c34e73646a615593b9c0b4a4cbd6f
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 DGKH FRMPD2B DNAH5 DNAH6 NBEA ODAD2 HYDIN CFAP46	1.21e-07	169	211	9	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 RYR2 PCDH10 DNAH5 FAT4 STAB2 ODAD2 DNAH1 HYDIN	2.49e-07	184	211	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 RYR2 PCDH10 DNAH5 FAT4 STAB2 ODAD2 DNAH1 HYDIN	2.49e-07	184	211	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 RYR2 PCDH10 DNAH5 FAT4 STAB2 ODAD2 DNAH1 HYDIN	2.49e-07	184	211	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	WWC3 DGKH DYSF GPR146 ARHGAP31 RNF213 ITIH5 RXFP1 CYB561	2.85e-07	187	211	9	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 HYDIN CFAP46	3.26e-07	190	211	9	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 HYDIN CFAP46	3.26e-07	190	211	9	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM67 MAP1A DNAH5 DNAH6 KLHL6 SYNE1 ODAD2 HYDIN CFAP46	4.06e-07	195	211	9	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 MAP1A FRMPD2B DNAH5 DNAH6 ODAD2 PPOX HYDIN CFAP46	4.06e-07	195	211	9	6365e3893e38231090ec2dbef010dec71dea3d07
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 MAP1A FRMPD2B DNAH5 DNAH6 NBEA ODAD2 HYDIN CFAP46	4.06e-07	195	211	9	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 MAP1A FRMPD2B DNAH5 DNAH6 NBEA ODAD2 HYDIN CFAP46	4.06e-07	195	211	9	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 MAP1A FRMPD2B DNAH5 DNAH6 NBEA ODAD2 HYDIN CFAP46	4.06e-07	195	211	9	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	droplet-Kidney-nan-21m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIR NLRC4 GGT5 FCER1G ADAMTSL4 P3H3 PDLIM4 IL1B	1.57e-06	170	211	8	510625bd725d3590cffcd7acd1d42219f6eb1139
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PLXND1 GREB1L ADAMTS13 ODAD2 ADAM12 NPTXR AGMAT	1.72e-06	120	211	7	a6d0406a174d46ce06b41280292931954af88a59
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ALLC ITPKA DIO3 VWA5B1 SYNE1 NPTXR MAPK1 NPAS4	1.94e-06	175	211	8	ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ALLC ITPKA DIO3 VWA5B1 SYNE1 NPTXR MAPK1 NPAS4	1.94e-06	175	211	8	21f8f11a8b874d4f7c47931010a2535f2a5a3373
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A FRMPD2B DNAH5 DNAH6 KLHL6 PPOX HYDIN CFAP46	2.40e-06	180	211	8	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	P03-Epithelial-airway_epithelial_cell-club_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN HYDIN CFAP46	2.50e-06	181	211	8	60a91587c59029a34e7bec1255083337fe21b72a
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	TMEM67 MAP1A CLSTN2 DNAH5 DNAH6 ODAD2 HYDIN CFAP46	2.60e-06	182	211	8	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	P07-Epithelial-airway_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN HYDIN CFAP46	2.82e-06	184	211	8	a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCell	P07-Epithelial-airway_epithelial_cell-club_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN HYDIN CFAP46	2.82e-06	184	211	8	ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN HYDIN CFAP46	3.44e-06	189	211	8	efee01edd171bf569267b672fab05c421de6c92d
ToppCell	facs-Heart-RA-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 RYR2 ITPKA CRACD KCNJ5 PLA2G5 CD177 RXFP1	3.44e-06	189	211	8	e4efbb0733b382f4c855f6653dcddf36e0f8df28
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN HYDIN CFAP46	3.44e-06	189	211	8	28c750ac56e3861fe7280e32839a4d8ce8bd8692
ToppCell	facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ITPKA DNAH5 DNAH6 ODAD2 TNN HYDIN CFAP46	3.58e-06	190	211	8	fe844559b95832845d2e8d3ab4b57e3d558bc372
ToppCell	facs-Lung-nan-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ITPKA DNAH5 DNAH6 ODAD2 TNN HYDIN CFAP46	3.58e-06	190	211	8	e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH ITGA5 DYSF GPR146 ARHGAP31 FAT4 RXFP1 CYB561	3.87e-06	192	211	8	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	Ciliated-cil-3\|World / Class top	STK36 DNAH5 DNAH6 CD177 SYNE1 ODAD2 DNAH1 HYDIN	3.87e-06	192	211	8	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	TMEM67 MAP1A DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	3.87e-06	192	211	8	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH ITGA5 DYSF GPR146 ARHGAP31 FAT4 RXFP1 CYB561	3.87e-06	192	211	8	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH ITGA5 DYSF GPR146 ARHGAP31 FAT4 RXFP1 CYB561	4.02e-06	193	211	8	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH ITGA5 DYSF GPR146 ARHGAP31 FAT4 RXFP1 CYB561	4.02e-06	193	211	8	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	TMEM67 MAP1A DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.02e-06	193	211	8	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYSF ARHGAP31 FAT4 SYNE1 ANO6 DNM3 RXFP1 SH3RF3	4.02e-06	193	211	8	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKH PARP4 DNAH5 SYNE1 RNF213 DNM3 PRKD1 HYDIN	4.18e-06	194	211	8	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 FRMPD2B DNAH5 DNAH6 SYNE1 NBEA HYDIN CFAP46	4.18e-06	194	211	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH5 DNAH6 CNN3 SYNE1 NBEA ODAD2 HYDIN CFAP46	4.34e-06	195	211	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH5 DNAH6 CNN3 SYNE1 NBEA ODAD2 HYDIN CFAP46	4.34e-06	195	211	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCGB3A1 FRMPD2B DNAH5 DNAH6 NBEA ODAD2 HYDIN CFAP46	4.34e-06	195	211	8	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 DYSF ARHGAP31 SYNE1 ANO6 DNM3 RXFP1 SH3RF3	4.34e-06	195	211	8	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	control-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PLXND1 JAK3 ANKAR RNF213 ADAM12 ZNF526 AGK PAM	4.34e-06	195	211	8	66959ae839eb60a573da06bdd227090ebb5bb9ed
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 FRMPD2B DNAH5 DNAH6 ODAD2 PPOX HYDIN CFAP46	4.34e-06	195	211	8	79dc031258579ea328181dda33710dd897f1064a
ToppCell	wk_15-18-Hematologic-Myeloid-Neutrophil\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CYP1B1 DYSF VSIR NLRC4 FCER1G ICAM3 IL1B PADI2	4.51e-06	196	211	8	36c01e0feea33448222010c21442b9fac671bd7d
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM67 MAP1A DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM67 MAP1A DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A FRMPD2B DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A FRMPD2B DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 CLSTN2 FRMPD2B DNAH5 DNAH6 SYNE1 HYDIN CFAP46	4.68e-06	197	211	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A FRMPD2B DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A FRMPD2B DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.68e-06	197	211	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF GGT5 GPR146 CNN3 STAB2 SYNE1 PDLIM4 ACSM2B	4.85e-06	198	211	8	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNST DYSF ARHGAP31 FAT4 SYNE1 DNM3 RXFP1 SH3RF3	4.85e-06	198	211	8	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM67 MAP1A DNAH5 DNAH6 SYNE1 ODAD2 HYDIN CFAP46	4.85e-06	198	211	8	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	droplet-Trachea\|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BPIFA1 SCGB3A1 PLA2G5 CNN3 FNDC3B P3H3 IFRD1 PAM	5.04e-06	199	211	8	1c7d30765ddb2291967da5d15664c6238c680c1d
ToppCell	droplet-Trachea\|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BPIFA1 SCGB3A1 PLA2G5 CNN3 FNDC3B P3H3 IFRD1 PAM	5.04e-06	199	211	8	b9038a1ccf3ef3123e2e39afbe6213c363437443
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP1B1 CLSTN2 ITGA5 SVEP1 GGT5 FAT4 SYNE1 SH3RF3	5.23e-06	200	211	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-7\|TCGA-Bladder / Sample_Type by Project: Shred V9	MAP1A NLRC4 TRPV2 CACNA1G KCNAB2 CUBN CDK5RAP2	7.53e-06	150	211	7	3ab17045b2c43bb4f0ebba6aa0cfb22e076a24f9
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1A DNAH5 DNAH6 ODAD2 DNAH1 HYDIN CFAP46	8.95e-06	154	211	7	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1A DNAH5 DNAH6 ODAD2 DNAH1 HYDIN CFAP46	8.95e-06	154	211	7	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	ASK452-Epithelial-Type_2\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	PRSS16 FGFR2 FERMT1 MRM3 FICD PRKD1 LRMDA	9.74e-06	156	211	7	e2b8d65c38cedb8ec6c3c1b138957145af931c51
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP1B1 SVEP1 RYR2 DNHD1 PCBP3 ADAM12 FAN1	1.06e-05	158	211	7	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRC4 FCER1G AP1G2 MAP3K14 KCNAB2 IL1B PADI2	1.06e-05	158	211	7	b0508a600994090c6aafd8d779437190a33ad821
ToppCell	facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRC4 FCER1G AP1G2 MAP3K14 KCNAB2 IL1B PADI2	1.06e-05	158	211	7	a816cc095452308d06f87b77467e2a8c6361fd2a
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 SVEP1 ITPKA IGLON5 ACAP3 ADAM12 IGDCC4	1.40e-05	165	211	7	4cdd80580d5638fd649280ba3893251c2f898f3f
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 SVEP1 ITPKA IGLON5 ACAP3 ADAM12 IGDCC4	1.40e-05	165	211	7	c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH6 CUBN DNAH1 FAN1 AGK HYDIN CFAP46	1.58e-05	168	211	7	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HFE DISC1 POT1 LCAT FICD DNM3 RNF182	1.58e-05	168	211	7	32e4d82efaccf336d347e4063253c3635a3ec672
ToppCell	droplet-Thymus-nan-18m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE BPIFA1 DNAH6 FERMT1 TNN AGMAT PRKD1	1.64e-05	169	211	7	4ac21e8199de4b6917eacadc56fffc6d886ee643
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 NFKBIA DNAH5 DNAH6 CUBN DNAH1 HYDIN	1.64e-05	169	211	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A GLYCTK TRPM5 PNPLA6 KCNAB2 ANO6 LRMDA	1.70e-05	170	211	7	c638dfde9ce30190abbe0caea1c3eb874af09857
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A HMCN2 KCNJ5 MYO18B CNN1 MST1R NPAS4	1.77e-05	171	211	7	09e653973962fb884878089d281f0947f7a285f6
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP6 ADAMTSL4 FNDC3B CD177 ICAM3 IL1B PADI2	1.77e-05	171	211	7	dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A HMCN2 KCNJ5 MYO18B CNN1 MST1R NPAS4	1.77e-05	171	211	7	82de2885c8ce4fb7776da6a0207b3355c0910121
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP6 ADAMTSL4 FNDC3B CD177 ICAM3 IL1B PADI2	1.77e-05	171	211	7	2b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH5 DNAH6 KLHDC9 IGFALS TNN HYDIN CFAP46	1.90e-05	173	211	7	a809be2630d2b91b53b82b5e2bb99e05524597c1
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST OTUD7B GPR146 KCNJ5 KLHL6 SYNE1 NPAS4	2.21e-05	177	211	7	84591e28482ab62a5ef41e61043eb64912766356
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK36 DNAH5 DNAH6 KLHDC9 TNN HYDIN CFAP46	2.21e-05	177	211	7	d5640f0097878f0dac671e51dc51310278bb2682
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST OTUD7B GPR146 KCNJ5 KLHL6 SYNE1 NPAS4	2.21e-05	177	211	7	4bc100062891d07cacd10ffba38966cc6302c92f
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST OTUD7B GPR146 KCNJ5 KLHL6 SYNE1 NPAS4	2.21e-05	177	211	7	9f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK36 DNAH5 DNAH6 KLHDC9 TNN HYDIN CFAP46	2.21e-05	177	211	7	d947ba38db1772fc5fdcdc211f7511c4aa699dee
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	INPPL1 FCER1G ARHGAP31 PCBP3 OVOS2 ITIH5 IL1B	2.29e-05	178	211	7	9e426ce23a4a33b91d139ad85685cf8483bcd01a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	BPIFA1 SCGB3A1 FCER1G CD177 CDK5RAP2 IL1B PADI2	2.29e-05	178	211	7	94a86f5232fffa6a92a30ea21fb44eec33b4d6c8
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	INPPL1 FCER1G ARHGAP31 PCBP3 OVOS2 ITIH5 IL1B	2.29e-05	178	211	7	c90e9048fc786ba8559972ae25c25ecab4bc1b7c
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 MAP1A RTN4RL1 DNAH1 CDK5RAP2 SH3RF3 MUTYH	2.37e-05	179	211	7	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAA1 CLSTN2 GGT5 KCNJ5 ADAM12 DNAH1 NPTXR	2.37e-05	179	211	7	69a1b3b05c921de6343ffe6ad998aa2b804312a7
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP1B1 DYSF SVEP1 NLRC4 ARHGAP31 SYNE1 ADAM12	2.37e-05	179	211	7	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAA1 CLSTN2 GGT5 KCNJ5 ADAM12 DNAH1 NPTXR	2.37e-05	179	211	7	479116ac65488c60104a053530830763ec1f95b2
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAA1 CLSTN2 GGT5 KCNJ5 ADAM12 DNAH1 NPTXR	2.37e-05	179	211	7	1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST KCNJ5 NBEAL2 KLHL6 SYNE1 MDGA1 NPAS4	2.46e-05	180	211	7	4e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST KCNJ5 NBEAL2 KLHL6 SYNE1 MDGA1 NPAS4	2.46e-05	180	211	7	ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCell	Ciliated_cells-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A DNAH5 DNAH6 ODAD2 DNAH1 HYDIN CFAP46	2.46e-05	180	211	7	bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST KCNJ5 NBEAL2 KLHL6 SYNE1 MDGA1 NPAS4	2.46e-05	180	211	7	466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNJ5 WDR72 DPH2 GSK3A IL1B	2.51e-05	73	211	5	582faedb369a099d0acf1565413e6b3ca2cfc564
ToppCell	P03-Epithelial-airway_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ITPKA DNAH5 DNAH6 FERMT1 ODAD2 TNN CFAP46	2.55e-05	181	211	7	1ea21d860d4d7abab3e21e130a16d044006656ee
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLSTN2 RYR2 CNN1 FAT4 ADAMTS13 NPTXR MDGA1	2.55e-05	181	211	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
Drug	BS35	LDHAL6A DECR1 LDHAL6B LDHA	2.23e-07	7	206	4	CID000029316
Drug	BS36	LDHAL6A DECR1 LDHAL6B LDHA	2.23e-07	7	206	4	CID000029308
Drug	tripotassium citrate monohydrate	LDHAL6A DECR1 LDHAL6B LDHA PRKD1	2.33e-07	16	206	5	CID002735208
Drug	thiazolyl blue	LDHAL6A JAK3 ICAM3 LDHAL6B LDHA IGFALS CYB561	2.41e-07	48	206	7	CID000064965
Drug	BS37	LDHAL6A DECR1 LDHAL6B LDHA	4.43e-07	8	206	4	CID000027925
Drug	benzamyl	LDHAL6A DECR1 LDHAL6B LDHA	7.92e-07	9	206	4	CID000160884
Drug	Bcdfg	LDHAL6A GGT5 LDHAL6B LDHA	7.92e-07	9	206	4	CID003036106
Drug	sodium oxamate	LDHAL6A DECR1 LDHAL6B LDHA	1.31e-06	10	206	4	CID000005242
Drug	alpha-ketovalerate	LDHAL6A ACAA1 DECR1 LDHAL6B LDHA	1.70e-06	23	206	5	CID000074563
Drug	thiourea	STK36 XIRP1 ACAA1 CLSTN2 DECR1 TRPV2 FERMT1 PPOX PADI2	2.57e-06	128	206	9	CID002723790
Drug	1-hydroxy-2-naphthoic acid	CYP1B1 NFKBIA MAPK1 IL1B	3.04e-06	12	206	4	ctd:C050175
Drug	Methamphetamine	MAP1A INPPL1 GLYCTK DGKH DYSF JAK3 KCNJ5 NFKBIA BANP ZNF638 PLA2G5 HERC2 MYO18B PCBP4 RNF31 PGGHG CD177 SYNE1 RTN4RL1 CUBN KLHDC9 GSK3A DNAH1 BAZ2A ANO6 AGMAT MAPK1 IL1B SH3RF3 NPAS4 MUTYH	3.56e-06	1401	206	31	ctd:D008694
Drug	diphenaldehyde	LDHAL6A GGT5 LDHAL6B LDHA	4.37e-06	13	206	4	CID000014585
Drug	beryllium nitrate	LDHAL6A GGT5 LDHAL6B LDHA	6.07e-06	14	206	4	CID000026126
Drug	scymnol	LDHAL6A LDHAL6B LDHA ABCB11	6.07e-06	14	206	4	CID000165531
Drug	AC1L3P2T	LDHAL6A GGT5 LDHAL6B LDHA	6.07e-06	14	206	4	CID000119585
Drug	spirobishexahydropyrimidine	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000100750
Drug	AC1O5TJF	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID006440410
Drug	1,4-diethoxybutane	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000232578
Drug	S-lac-NAD	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000194292
Drug	sorbarin	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID009824100
Drug	AC1O5ZB9	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID006443605
Drug	AC1L49DG	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000152931
Drug	N-trifluoroacetyl-glycine	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000136227
Drug	acetylphosphonic acid	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000081311
Drug	NSC-60195	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000020481
Drug	ethyl gossypol	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000374353
Drug	oxyayanin A	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID005281676
Drug	B-HAD	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000131338
Drug	SQ 31,486	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000130015
Drug	BMS-188107	LDHAL6A LDHAL6B LDHA	7.20e-06	5	206	3	CID000192297
Drug	Ac-YVAD-Amc	LDHAL6A LDHAL6B LDHA IL1B	8.22e-06	15	206	4	CID000004337
Drug	2-bromohydroquinone	LDHAL6A GGT5 LDHAL6B LDHA	8.22e-06	15	206	4	CID000068502
Drug	potassium citrate	LDHAL6A LDHAL6B LDHA PRKD1	1.09e-05	16	206	4	CID000013344
Drug	pheophytin	HFE LDHAL6A ACAA1 GGT5 DECR1 LDHAL6B LCAT LDHA PPOX TGM4 ABCB11 PRKD1	1.16e-05	284	206	12	CID000000250
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A	SVEP1 NBEAL2 PGGHG ADAMTS13 PTPN21 GSK3A MST1R BAZ2A TNN IL1B	1.31e-05	197	206	10	5529_UP
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	CYP1B1 MAP1A PRSS16 UNC45A NBEAL2 PEX5 AP1G2 DPH2 PTPN21 ADAM12	1.37e-05	198	206	10	6362_DN
Drug	BL-443	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000054436
Drug	dansyl-L-lysine	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000598797
Drug	I 65	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000149068
Drug	D 701	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID003051460
Drug	2,3-dihydroxy-1-naphthoic acid	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000028002
Drug	AC1L24G8	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000066023
Drug	oxymethacil	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000096369
Drug	SQ 32,926	LDHAL6A LDHAL6B LDHA	1.43e-05	6	206	3	CID000131363
Drug	AC1L1B55	CYP1B1 LDHAL6A ITGA5 ITPKA DECR1 NFKBIA SLX1A MAP3K14 LDHAL6B LDHA GSK3A IGDCC4 PRKD1 MAPK1 IL1B	1.79e-05	454	206	15	CID000001287
Drug	4-methoxy-1-naphthaldehyde	LDHAL6A GGT5 LDHAL6B LDHA	1.80e-05	18	206	4	CID000085217
Drug	AC1O7170	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID006540699
Drug	pentabromoacetone	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID000065579
Drug	methyl-4-hydroxy-3-nitrobenzimidate	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID005492576
Drug	gossylic iminolactone	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID005479302
Drug	N-acetyl-9-O-lactylneuraminic acid	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID000191486
Drug	sodium glycolate	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID000517347
Drug	AC1NSM0G	LDHAL6A LDHAL6B LDHA	2.49e-05	7	206	3	CID005365671
Drug	fargesin	XIRP1 IL1B YME1L1	2.49e-05	7	206	3	CID000129290
Drug	palladium	ACAA1 DNAH5 SYNE1 AGK PAM PADI2	3.50e-05	68	206	6	CID000023938
Drug	p-(phenoxypropoxy)aniline	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000423258
Drug	U75412E	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID003035460
Drug	AC1Q3O0A	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000060880
Drug	UR-12633	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000128030
Drug	2-methyl-2-pentenoate	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000018458
Drug	AC1L4GHU	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000156607
Drug	N-dodecyl morpholine	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000073764
Drug	S-(2-chloroethyl)-L-cysteine	LDHAL6A LDHAL6B LDHA	3.95e-05	8	206	3	CID000034229
Drug	2 MAC	LDHAL6A DECR1 LDHAL6B LDHA	4.19e-05	22	206	4	CID000005624
Drug	HMR 1098	LDHAL6A LDHAL6B LDHA GSK3A	4.19e-05	22	206	4	CID003037766
Drug	2-ethylhexanol	CYP1B1 LDHAL6A LDHAL6B LDHA	4.19e-05	22	206	4	CID000007720
Drug	hydroxymalonate	LDHAL6A ACAA1 DECR1 LDHA	5.04e-05	23	206	4	CID000000044
Drug	AcPyAD	LDHAL6A DECR1 LDHAL6B LDHA	5.04e-05	23	206	4	CID000002010
Drug	7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one	NFKBIA MAPK1 IL1B	5.89e-05	9	206	3	ctd:C502972
Drug	N-acetyl-ala-ala-ala-methyl ester	LDHAL6A LDHAL6B LDHA	5.89e-05	9	206	3	CID000100120
Drug	2-acetolactate	LDHAL6A DECR1 LDHAL6B LDHA	6.00e-05	24	206	4	CID000000022
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A	KCNJ5 AP1G2 CACNA1G FGFR2 PCBP4 CNN1 BAZ2A PADI2 CYB561	6.62e-05	192	206	9	3087_UP
Drug	carbon tetrachloride	LDHAL6A CLSTN2 GGT5 DECR1 NFKBIA LDHAL6B LDHA ABCB11 PRKD1 IL1B	7.04e-05	240	206	10	CID000005943
Drug	Phenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A	HFE ACAA1 DISC1 DYSF BAHCC1 STAB2 IPO8 RPAP1 IL1B	7.17e-05	194	206	9	4111_DN
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	PLXND1 SVEP1 GREB1L KCNJ5 BAHCC1 SYNE1 GSK3A PDLIM4 IL1B	7.46e-05	195	206	9	3300_UP
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	MAP1A SVEP1 GREB1L CNN1 TGM4 BAZ2A PAM IL1B ZNF646	7.46e-05	195	206	9	3366_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A	HFE MAP1A CLSTN2 RYR2 PLA2G5 PTPN21 GSK3A SP140 ZNF646	7.46e-05	195	206	9	3199_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; HL60; HG-U133A	ACP6 HFE NBEAL2 TRPV2 ADAMTS13 ADAM12 PADI2 YME1L1 CYB561	8.07e-05	197	206	9	1388_UP
Drug	proadifen hydrochloride	CYP1B1 LDHAL6A CLSTN2 DECR1 LDHAL6B MIB2 LDHA	8.14e-05	114	206	7	CID000004910
Drug	phosphorus pentasulfide	ACAA1 SYNE1	8.15e-05	2	206	2	CID000014817
Drug	zolimidine	STK36 ACAA1	8.15e-05	2	206	2	CID000014652
Drug	hydroxyisonobilin	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID006438562
Drug	pyridinophane cryptand	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID006454246
Drug	FK3311	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID000164009
Drug	2-keto-4-mercaptobutyric acid	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID000151198
Drug	bis-NAD	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID003081557
Drug	mivazerol	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID000060783
Drug	sargachromanol G	NFKBIA MAPK1 IL1B	8.36e-05	10	206	3	ctd:C577249
Drug	phosphoenolthiopyruvate	LDHAL6A LDHAL6B LDHA	8.36e-05	10	206	3	CID000194910
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; PC3; HG-U133A	HFE TRPV2 AP1G2 ADAM12 PDLIM4 NBAS BAZ2A PCBP2 PADI2	8.39e-05	198	206	9	1934_UP
Drug	Pipemidic acid [51940-44-4]; Up 200; 13.2uM; HL60; HT_HG-U133A	HFE CYP1B1 RYR2 ITPKA KCNJ5 TTC38 FAT4 KCNAB2 ZNF646	8.39e-05	198	206	9	3093_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HFE CYP1B1 SVEP1 HPS4 CACNA1G PCBP3 PTPN21 BAZ2A IL1B	8.72e-05	199	206	9	2232_UP
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A	PLXND1 KCNJ5 NBEAL2 DPH2 NCAPD3 PGGHG SLC4A2 BAZ2A IL1B	8.72e-05	199	206	9	498_DN
Drug	phenanthrene	HFE CYP1B1 ALLC DECR1 PARP4 PPY	1.01e-04	82	206	6	CID000000995
Drug	AC1NPP2V	LDHAL6A GGT5 ICAM3 LDHAL6B LDHA PRKD1	1.01e-04	82	206	6	CID005207744
Drug	1-acetyl-sn-glycero-3-phosphocholine	LDHAL6A SSC4D PNPLA6 PLA2G5 LDHAL6B LCAT LDHA PAM PRKD1 MAPK1 IL1B	1.12e-04	305	206	11	CID005311264
Drug	pentachlorophenol	LDHAL6A DECR1 DNAH5 SLX1A LDHAL6B LDHA IL1B	1.12e-04	120	206	7	CID000000992
Drug	PCB 66	RYR2 DECR1 PCBP2	1.14e-04	11	206	3	CID000036185
Drug	hexandiol	LDHAL6A LDHAL6B LDHA	1.14e-04	11	206	3	CID000147023
Disease	glucuronate measurement	PTDSS1 WDR72 FNDC3B MAPK1	6.17e-06	18	203	4	EFO_0010486
Disease	Primary Ciliary Dyskinesia	STK36 DNAH5 ODAD2 DNAH1 HYDIN	1.78e-05	47	203	5	C4551720
Disease	Porphyria, South African type	HFE PPOX	4.71e-05	2	203	2	C2936913
Disease	Variegate Porphyria	HFE PPOX	4.71e-05	2	203	2	C0162532
Disease	variegate porphyria (is_implicated_in)	HFE PPOX	4.71e-05	2	203	2	DOID:4346 (is_implicated_in)
Disease	Myoglobinuria	LPIN1 LDHA	4.71e-05	2	203	2	C0027080
Disease	Gastric cancer	FGFR2 IL1B MUTYH	5.08e-05	11	203	3	cv:C0024623
Disease	Neoplasm of stomach	FGFR2 IL1B MUTYH	5.08e-05	11	203	3	cv:C0038356
Disease	GASTRIC CANCER	FGFR2 IL1B MUTYH	5.08e-05	11	203	3	613659
Disease	Kartagener Syndrome	STK36 ODAD2 DNAH1 HYDIN	9.63e-05	35	203	4	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	STK36 ODAD2 DNAH1 HYDIN	9.63e-05	35	203	4	C4551906
Disease	Polynesian Bronchiectasis	STK36 ODAD2 DNAH1 HYDIN	9.63e-05	35	203	4	C4317124
Disease	Primary ciliary dyskinesia	DNAH5 ODAD2 DNAH1 HYDIN	1.08e-04	36	203	4	cv:C0008780
Disease	Sjogren's syndrome (implicated_via_orthology)	NFKBIA MAP3K14 MUC19	2.03e-04	17	203	3	DOID:12894 (implicated_via_orthology)
Disease	nephrotic syndrome (is_marker_for)	NFKBIA IGFALS IL1B	2.43e-04	18	203	3	DOID:1184 (is_marker_for)
Disease	hydrocephalus (implicated_via_orthology)	TMEM67 STK36 HYDIN	2.87e-04	19	203	3	DOID:10908 (implicated_via_orthology)
Disease	disease of metabolism (implicated_via_orthology)	LDHAL6A LDHAL6B LDHA	3.89e-04	21	203	3	DOID:0014667 (implicated_via_orthology)
Disease	Profound Mental Retardation	DISC1 CACNA1G FGFR2 ZCCHC8 AP4E1 ZNF526	4.14e-04	139	203	6	C0020796
Disease	Mental Retardation, Psychosocial	DISC1 CACNA1G FGFR2 ZCCHC8 AP4E1 ZNF526	4.14e-04	139	203	6	C0025363
Disease	Mental deficiency	DISC1 CACNA1G FGFR2 ZCCHC8 AP4E1 ZNF526	4.14e-04	139	203	6	C0917816
Disease	Nasopharyngeal carcinoma	NFKBIA SYNE1 MST1R	4.49e-04	22	203	3	C2931822
Disease	Cystic kidney	TMEM67 FAT4	6.94e-04	6	203	2	C0022679
Disease	cystic fibrosis (is_implicated_in)	HFE AGER IL1B	8.31e-04	27	203	3	DOID:1485 (is_implicated_in)
Disease	myocardial infarction (implicated_via_orthology)	CYP1B1 LCAT MAPK1 IL1B	1.12e-03	66	203	4	DOID:5844 (implicated_via_orthology)
Disease	Developmental Coordination Disorder	DISC1 FGFR2	1.28e-03	8	203	2	C0011757
Disease	phenol sulfate measurement	MYO18B PRKD1	1.28e-03	8	203	2	EFO_0021011
Disease	Motor Skills Disorders	DISC1 FGFR2	1.28e-03	8	203	2	C0026613
Disease	ureteral obstruction (implicated_via_orthology)	MAPK1 IL1B	1.64e-03	9	203	2	DOID:5199 (implicated_via_orthology)
Disease	Megaconial Myopathies	FDX2 IL1B	1.64e-03	9	203	2	C0162668
Disease	Pleoconial Myopathies	FDX2 IL1B	1.64e-03	9	203	2	C0162669
Disease	Luft Disease	FDX2 IL1B	1.64e-03	9	203	2	C0949496
Disease	encephalitis (biomarker_via_orthology)	NFKBIA IL1B	1.64e-03	9	203	2	DOID:9588 (biomarker_via_orthology)
Disease	Hypermetropia, Myopia	TMEM67 C2CD5 FRMPD2B PCBP3 KCNAB2 CUBN	2.03e-03	189	203	6	HP_0000540, HP_0000545
Disease	Asthma, Occupational	HERC2 PRKD1	2.04e-03	10	203	2	C0264423
Disease	prostate adenocarcinoma (is_marker_for)	NFKBIA PAM	2.04e-03	10	203	2	DOID:2526 (is_marker_for)
Disease	visceral heterotaxy (implicated_via_orthology)	TMEM67 DNAH5 ODAD2	2.10e-03	37	203	3	DOID:0050545 (implicated_via_orthology)
Disease	Mitochondrial Myopathies	FDX2 IL1B	2.49e-03	11	203	2	C0162670
Disease	Cystic Kidney Diseases	TMEM67 FAT4	2.49e-03	11	203	2	C1691228
Disease	collagen disease (implicated_via_orthology)	NFKBIA DNM3	2.97e-03	12	203	2	DOID:854 (implicated_via_orthology)
Disease	Trigeminal Neuralgia	MAPK1 IL1B	2.97e-03	12	203	2	C0040997
Disease	Secondary Trigeminal Neuralgia	MAPK1 IL1B	2.97e-03	12	203	2	C0393787
Disease	Trigeminal Neuralgia, Idiopathic	MAPK1 IL1B	2.97e-03	12	203	2	C0393786
Disease	stomach carcinoma (is_implicated_in)	FGFR2 MUTYH	2.97e-03	12	203	2	DOID:5517 (is_implicated_in)
Disease	periodontitis (is_marker_for)	AGER IL1B	2.97e-03	12	203	2	DOID:824 (is_marker_for)
Disease	Schizophrenia	PRSS16 DISC1 PGBD1 AGER HPS4 DIO3 FGFR2 PTPN21 ADAM12 GSK3A MAPK1 IL1B MDGA1 NPAS4	3.35e-03	883	203	14	C0036341
Disease	salicylurate measurement	RYR2 ZNF638	3.49e-03	13	203	2	EFO_0010532
Disease	Intellectual Disability	DISC1 CACNA1G FGFR2 TFB2M ZCCHC8 SYNE1 NBEA AP4E1 ZNF526	3.97e-03	447	203	9	C3714756
Disease	Kawasaki disease (is_marker_for)	AGER IL1B	4.06e-03	14	203	2	DOID:13378 (is_marker_for)
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH5 ODAD2	4.06e-03	14	203	2	DOID:0050144 (implicated_via_orthology)
Disease	chronic kidney disease (is_implicated_in)	AGER IL1B	4.06e-03	14	203	2	DOID:784 (is_implicated_in)
Disease	albuminuria	BAHCC1 CUBN RPAP1 LRMDA	4.09e-03	94	203	4	EFO_0004285
Disease	Hereditary Diffuse Gastric Cancer	ITGA5 FGFR2 FAT4 NBAS MAPK1 IL1B MUTYH	4.32e-03	293	203	7	C1708349
Disease	Stomach Neoplasms	ITGA5 FGFR2 FAT4 NBAS MAPK1 IL1B MUTYH	4.65e-03	297	203	7	C0038356
Disease	Malignant neoplasm of stomach	ITGA5 FGFR2 FAT4 NBAS MAPK1 IL1B MUTYH	4.91e-03	300	203	7	C0024623
Disease	coronary artery disease (is_implicated_in)	ARHGAP31 AGER CUBN BTNL2	5.10e-03	100	203	4	DOID:3393 (is_implicated_in)
Disease	Benign neoplasm of stomach	FGFR2 MUTYH	5.98e-03	17	203	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	FGFR2 MUTYH	5.98e-03	17	203	2	C0496905
Disease	muscular dystrophy (is_implicated_in)	DYSF SYNE1	5.98e-03	17	203	2	DOID:9884 (is_implicated_in)
Disease	Astrocytosis	ITGA5 MAPK1	5.98e-03	17	203	2	C3887640
Disease	Carcinoma in situ of stomach	FGFR2 MUTYH	5.98e-03	17	203	2	C0154060
Disease	Gliosis	ITGA5 MAPK1	5.98e-03	17	203	2	C0017639
Disease	Bipolar Disorder	DISC1 DGKH FGFR2 SYNE1 LDHA GSK3A MAPK1 IL1B MDGA1	6.02e-03	477	203	9	C0005586
Disease	clonal hematopoiesis mutation measurement	FGFR2 HERC2 NEUROD4	6.47e-03	55	203	3	EFO_0020949
Disease	alcoholic hepatitis (biomarker_via_orthology)	NFKBIA ABCB11	6.70e-03	18	203	2	DOID:12351 (biomarker_via_orthology)
Disease	serum hepcidin measurement	HFE DGKH	6.70e-03	18	203	2	EFO_0004504
Disease	Hypertrophy	AGER MAPK1	6.70e-03	18	203	2	C0020564
Disease	non-alcoholic fatty liver disease (is_implicated_in)	HFE IL1B	6.70e-03	18	203	2	DOID:0080208 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VGQDGQLLEATRIPC	BANP	421	Q8N9N5
GVVFCLLGAQPLLVI	SLC4A2	751	P04920
QELQCAALLEAGGPE	BAHCC1	1186	Q9P281
LQASQCTLLIPEGAG	AGK	366	Q53H12
LSLPQLCLDQEVLSG	ADAMTSL4	16	Q6UY14
GVGEDALLTCQLLPK	BTNL2	41	Q9UIR0
LENDENGILLVPGCE	ALLC	246	Q8N6M5
LDGQNLPSLVCVITG	ALG1L2	91	C9J202
VPSLGVLQEGLLCQG	BAZ2A	876	Q9UIF9
VLQEGLLCQGDSLGE	BAZ2A	881	Q9UIF9
LLCQGDSLGEVQDLL	BAZ2A	886	Q9UIF9
AAQGILDQCPRLEGA	FAT4	4151	Q6V0I7
QGEPLEKLNLRGCEV	FERMT1	411	Q9BQL6
DLSQGIQPVQGLALC	AP1G2	111	O75843
AQLGSLQPLSVGCVE	CFAP46	1936	Q8IYW2
GCERVALQFPDQLLG	DPH2	46	Q9BQC3
VIVGALNLGNASPCL	ABCB11	366	O95342
PLVQAVLGGSLIVCE	ACAP3	706	Q96P50
GSLEPQALLGLENLC	IGFALS	111	P35858
LVPLLGQLCVADREN	PAM	691	P19021
IETNIPLQQGGRILC	ADAM12	601	O43184
ISGGLEVLAEKCPNL	ANP32E	76	Q9BTT0
GQVCQETLLLLDVGL	CD177	241	Q8N6Q3
CRGLPTDLLLQQVEA	DNHD1	3341	Q96M86
LPVLLTNVELGLGCE	DNHD1	3686	Q96M86
PEGVLANVLGLLLAC	CYB561	196	P49447
FCDILVIGGDLDPRQ	CLSTN2	696	Q9H4D0
PFLLEGNGTEELCLL	CC2D2B	601	Q6DHV5
GCDLTPLVGQLSLGQ	DISC1	501	Q9NRI5
GEEILLDTQCQGLPR	ADAMTS13	986	Q76LX8
GSELELPVIQLCGLV	CCDC113	16	Q9H0I3
IEIIGNEGLLACQLL	AP4E1	1081	Q9UPM8
GCLEEGAFINLLAPL	CDK5RAP2	766	Q96SN8
ILGPEQAAVLNCSLG	IGDCC4	46	Q8TDY8
DIINCIGGLNVLFPL	NBEAL1	866	Q6ZS30
LQGECLAPLGALEFL	RTN4RL1	236	Q86UN2
LPAVGIQDEGIFRCQ	AGER	86	Q15109
RNCIPIGEQLQSVLG	PAAT	216	Q9H8K7
PVGLSLKEQGECLSL	JAK3	151	P52333
GLLTPAECGVLLQLA	P3H3	471	Q8IVL6
CPEGIILLLVQAILG	KCNJ5	161	P48544
VPCILGQNGISDLVK	LDHA	291	P00338
EDLLENVLGCIPVGQ	LTN1	1446	O94822
EAGGIPSLINLLVCD	ANKAR	781	Q7Z5J8
DPGGCLLELTTQLTI	ANO6	596	Q4KMQ2
GAKVNCENIDGILPL	ANKRD31	1211	Q8N7Z5
ENVTVQCLLTGGDPL	MDGA1	256	Q8NFP4
VILSVQCGTLLPVNG	PAXIP1	76	Q6ZW49
QRLLPLATTGDGNCL	OTUD7B	181	Q6GQQ9
NIINLLGACTQDGPL	FGFR2	546	P21802
LGILGSPSQEDLNCI	MAPK1	241	P28482
FLVPNDLIGCVIGRQ	PCBP4	246	P57723
ADCILIVGLGDQEPT	PNPLA6	871	Q8IY17
FQDLDLCPLDGGIQL	IL1B	36	P01584
VPNNCLGEVTINGDL	PRKD1	316	Q15139
KGQLCGVVLDLIPSN	MDN1	4341	Q9NU22
TEALNPENCVGILRL	KLHL6	166	Q8WZ60
LLGNVACPNELVSLE	LRMDA	81	Q9H2I8
PVNIDEGLTGCTIQL	MAP1A	1076	P78559
EGLTGCTIQLLPAQD	MAP1A	1081	P78559
GLLQALQSPCIIEGE	NLRC4	156	Q9NPP4
GLFETLCDQLLDIPG	NLRC4	211	Q9NPP4
CFNIDGQPGDILRLV	ITIH5	696	Q86UX2
DGGDRLVLPCNQSVV	ITIH5	766	Q86UX2
VELCAGLVDQPGLSL	NUDT14	101	O95848
GLVDQPGLSLEEVAC	NUDT14	106	O95848
GGLVACRVTELQQQP	LRRC59	261	Q96AG4
GPIQCEGLANLGVTQ	HERC2	441	O95714
VLQQGAPGCALVLDT	DIO3	231	P55073
GLAPGQLVLECSVEA	HMCN2	3606	Q8NDA2
LLPLGAVEEQCLAVL	FICD	41	Q9BVA6
LLDQQELLCGQIAGV	HPS4	46	Q9NQG7
SQVCPLIGEILGQLD	BPIFA3	206	Q9BQP9
SCLLELPQIAVVGGQ	DNM3	26	Q9UQ16
RLGCQIVLTPELEGA	FDX2	151	Q6P4F2
KILQLDPGQGLVVVC	PLXND1	126	Q9Y4D7
PCILGENGITNLIKI	LDHAL6B	341	Q9BYZ2
QIPIDLTLQNCSGGA	MUC19	1166	Q7Z5P9
IDPDVQCGLGVLFNL	PEX5	486	P50542
GELQPDLCFLLVSGR	FAM234B	281	A2RU67
LLVEQAAALGEPQLC	FCER1G	11	P30273
TCPGIVNGALELERN	ABCC11	486	Q96J66
LVAGPEVEEQCRQLG	PDZD3	296	Q86UT5
GLNPATLSGCIDIIV	LPIN1	21	Q14693
TNQPEIAEALLGAGC	NFKBIA	121	P25963
ECGLDVVGPLQLRQA	PGGHG	241	Q32M88
DCPAQLQQLLELGRG	HFE	186	Q30201
LLHGSPVQNIVGILC	PARP4	436	Q9UKK3
NVGLILIAICGEEGL	OVOS2	1231	Q6IE36
GQVQCELLGDVPFRL	PCDH10	391	Q9P2E7
GQGAILLVNCDRETP	PADI2	146	Q9Y2J8
PLICDGIIQGIDSFV	PRTN3	206	P24158
LNKQCQLGVLPLGTG	DGKH	406	Q86XP1
LPLGQEEQCSVALGE	PLA2G4F	281	Q68DD2
QDLDGLPCIVILTGK	GREB1L	1026	Q9C091
GCLEEFGVKILPLQV	NBAS	1221	A2RRP1
AQVLGIANCTAPLLG	NPTXR	456	O95502
ELQAIAERLGCTLPQ	KCNAB2	291	Q13303
CVALLLQPLLGAQGA	PPY	16	P01298
HELTIPNDLIGCIIG	PCBP3	296	P57721
CLLTPGVQGQEFLLR	ICAM3	21	P32942
LQLQDLLDGFDGPCV	ITPKA	246	P23677
GSIPCTLEQAIQLAG	PTPN21	131	Q16825
ELTIPNDLIGCIIGR	PCBP2	291	Q15366
LACSVPAVQGGLLDL	PLA2G5	11	P39877
ISLGLPVGAVINCAD	RPL23	16	P62829
SQGVLELSCPQALEG	ITGA5	841	P08648
PGNGDCTLLALAQLR	NPAS4	581	Q8IUM7
IPCGRLGTVEELANL	DECR1	266	Q16698
LAQQLAVLCGREIPG	CUBN	2046	O60494
PGLDNQTLGVCQRLV	GAL3ST2	356	Q9H3Q3
ILSPGTLDQLGEVCR	DNAH1	101	Q9P2D7
GILQCDPGTIREEIQ	DNAH6	2306	Q9C0G6
PVTVNEGGNVNLLCL	IGLON5	141	A6NGN9
LRCQIIEPNISEGGE	HYDIN	3136	Q4G0P3
AGCVLAELLLGQPIF	GSK3A	306	P49840
GNVCPLVNEVLRGLD	BPIFA1	221	Q9NP55
GQNETEPIVLEGKCL	CBLN1	21	P23435
PVCLLAGGEPTVQLQ	GLYCTK	401	Q8IVS8
QLSCIQLPVDSQGGD	CACNA1G	981	O43497
FPGDRLLQVDGVILC	FRMPD2B	6	Q6IN97
IRAEDGTLQCIQGPA	FNDC3B	51	Q53EP0
ILVTGAQLCGPAVNL	CRACD	596	Q6ZU35
RLIQCGLLVAEETPG	GPAT2	621	Q6NUI2
LLDQCAQALPLGTGA	GGT5	121	P36269
VLCIQLGPGIESEEI	IFRD1	151	O00458
GPQDLAALLEQIGCL	ANKS3	426	Q6ZW76
GEGLVLRPLCTADLN	GNPNAT1	36	Q96EK6
LLLFGGCNLAEPEVA	KLHDC9	206	Q8NEP7
LVPGCLGNQLEAKLD	LCAT	51	P04180
QIRLGSCPIVVLNGE	CYP1B1	86	Q16678
DLPSLIQEGPQCGLV	C19orf54	121	Q5BKX5
GLVEELPACQDLQLG	GPR146	11	Q96CH1
SLALPGLQGCAELRQ	GRK7	36	Q8WTQ7
GICILLNGVIPQDQS	SLC22A6	406	Q4U2R8
IGLNICAPGDQELIA	RYR2	3476	Q92736
QLTDELIAGCSQPLG	DYSF	711	O75923
LNPRFLQDGTVEGCL	C2CD5	436	Q86YS7
NLDTCPEGTILGLRL	NEURL4	1236	Q96JN8
CGNNQISDLGILLPE	CNST	511	Q6PJW8
VQCCVGDETLGQLLP	DNAH5	1676	Q8TE73
SLGQLVKEQGCLPED	MAP3K14	476	Q99558
VGLVPLLVDAGCSVN	MIB2	681	Q96AX9
GRGIDQCIPLFVQLV	IPO8	751	O15397
GGVLQLCPDTETRLN	TMEM67	351	Q5HYA8
PGVELGVENGLLCQL	GARIN1A	16	Q6NXP2
GVENGLLCQLIHSPE	GARIN1A	21	Q6NXP2
QQAQDLVSCLGGPVL	FAN1	926	Q9Y2M0
DLNIQEQCESLGPGL	PSAPL1	206	Q6NUJ1
LCASIEGINRQVEPL	YARS1	441	P54577
VNLRPEQLGDICVGN	ACAA1	76	P09110
EQLGDICVGNVLQPG	ACAA1	81	P09110
SASPGELCLVQVGLL	TDRD6	66	O60522
NLPSEVLGCVLAGLV	TDRD6	121	O60522
LLEVLSGQKLPCEQG	SYNE1	66	Q8NF91
LQGAPGLCVAELELL	TMEM132B	176	Q14DG7
LLICDNLRDPGNLGT	MRM3	211	Q9HC36
CGGIQPLVNLLVGIN	ODAD2	796	Q5T2S8
LVQCQGPAIIGALLR	NBEAL2	971	Q6ZNJ1
DNIIIACGGILPLLS	NBEA	1391	Q8NFP9
AALCPGDLIQAINGE	PDLIM4	41	P50479
RNLGQTNEGLIPVCV	SPATA31A7	736	Q8IWB4
PLSNECLLLIEGGTL	POT1	446	Q9NUX5
NQGLVCALLLPVEGE	INPPL1	106	O15357
ECNPGPGILTQALLE	TFB2M	101	Q9H5Q4
LTPSQALEIIRGCQG	AGMAT	296	Q9BSE5
TCVLEQPGALGAQIL	MUTYH	371	Q9UIF7
IELPNTGRIGQLLVC	TGM4	591	P49221
GPGEAALQELCGQLE	WHAMM	136	Q8TF30
LPDDNNILVNLTCGG	RNF182	81	Q8N6D2
GVSLECQSLQLLPGI	PGBD1	151	Q96JS3
DLVGSSIILCLPNGL	SVEP1	411	Q4LDE5
PEGLGEELLQCEVPQ	STK36	1221	Q9NRP7
LQNCLAGGESLLPET	ACSM2B	331	Q68CK6
LLEGCQVPGGSQELV	ANHX	81	E9PGG2
EGRSQGNDILCLSLP	NCAPD3	1446	P42695
DGIILCEFINKLQPG	CNN1	56	P51911
PNFQLGLKDGIILCE	CNN3	46	Q15417
AGICLQPLQQGDALL	RNF31	391	Q96EP0
VLRGQPVCGLSLQAE	PPOX	251	P50336
AAVLLCGQNELLEPL	RNF213	4451	Q63HN8
GALLDNGSVVPNCDI	ZCCHC8	621	Q6NZY4
ELEGRCQLPALGLLQ	TRIM11	231	Q96F44
LCLLVNGDPNTLERI	TRPM5	226	Q9NZQ8
RNLGQTNEGLIPVCV	SPATA31A5	736	Q5VU36
GLDCAQVVTPQGLQL	TNN	256	Q9UQP3
LSGVGQLLAELQCQL	PRR19	141	A6NJB7
ALCAGPEELGLQVQQ	SSC4D	441	Q8WTU2
VGCGVDELPANILLV	SH3RF3	101	Q8TEJ3
ILGICNEPEFLGIVT	RIPK2	81	O43353
EGQNVTLTCRLLGPV	VSIR	46	Q9H7M9
DGLLQAGARLCPTVQ	TRPV2	271	Q9Y5S1
QVGIPRGLENNCDSL	WDR72	881	Q3MJ13
LCIQGGESLLEAQPR	ZNF646	1036	O15015
NSEELLVLICGPGAE	MTERF1	266	Q99551
LVLICGPGAEILDLS	MTERF1	271	Q99551
LQLVESVRQPGCLLE	RNH1	416	P13489
LVGSVPVQCLCQGLE	RXFP1	96	Q9HBX9
GDGIVCLEINPCLEN	STAB2	1506	Q8WWQ8
LLAGLFQCQKEGPII	ACP6	176	Q9NPH0
QTVSPGLLCGELAEN	ARHGAP31	1381	Q2M1Z3
LCGQLAAILAAPGLQ	RPAP1	911	Q9BWH6
PQAVCEILGLQGSEV	TBC1D15	621	Q8TC07
LCLLGAGPLEAQVTQ	TRBV27	11	A0A0K0K1C4
QDLEGLIGTLCDQIG	MYO18B	1776	Q8IUG5
IDQLVENLLPGFCKG	YME1L1	131	Q96TA2
GLPLCQALVEAEDGN	TTC38	376	Q5R3I4
GECSQLILSPGELLA	ZNF526	111	Q8TF50
LQEEPGQLLPLEGQC	SLX1A	221	Q9BQ83
QVTNEGEPEKGLCLL	SP140	306	Q13342
LELGRLVSPGNCDTL	TP53TG3	71	Q9ULZ0
GPAAQLCLGELAVVQ	ZSWIM1	336	Q9BR11
ENCGVPEDLLNGLKV	TTC1	6	Q99614
IEICLEPLQKGENLG	USP40	1051	Q9NVE5
QTGAPLSVRQLCGLL	PRSS16	301	Q9NQE7
DQVILDILLCNGGGI	PTDSS1	216	P48651
SLQLGQDGAPLQVCV	MST1R	921	Q04912
PELQQLLACGLGTSV	XIRP1	876	Q702N8
LIEGSQKCVAELGPQ	SCGB3A1	71	Q96QR1
LLQGPCDAGNRALEL	UNC45A	421	Q9H3U1
LPEDGLQCVLCVGLQ	ZNF638	1016	Q14966
CSVTPQLQEELLGIA	WWC3	691	Q9ULE0
KLQLAVLQGLGPLCE	TTI1	981	O43156
QLEIRGPCLLAGVES	VWA5B1	226	Q5TIE3
DIFLSVPCILGENGI	LDHAL6A	286	Q6ZMR3
VPCILGENGITDLIK	LDHAL6A	291	Q6ZMR3
AGCLQLGPQSVLLEK	NEUROD4	171	Q9HD90